In short, parents seeking safer long-term options for their child’s eczema have several effective non-steroidal alternatives available.
- Topical Calcineurin Inhibitors (TCIs): These medications suppress the immune system in the skin to reduce inflammation without thinning the skin.
- Phosphodiesterase-4 (PDE4) Inhibitors: This newer class of ointment blocks specific enzymes to stop inflammation deep within the skin cells.
- Biologic Therapies: Injectable treatments that target specific pathways in the immune system are now available for children with moderate-to-severe eczema.
Non-steroidal treatment for pediatric atopic dermatitis is becoming an increasingly popular topic among parents who worry about the long-term effects of corticosteroids. While topical steroids remain the gold standard for flare-ups, they are not always suitable for sensitive areas or prolonged use.
Fortunately, medical science has advanced significantly. There are now several FDA-approved non-steroidal options that manage inflammation effectively.
These treatments offer hope for children suffering from chronic itch and discomfort. Understanding these options empowers you to have informed conversations with your dermatology provider.
Why Choose a Non-Steroidal Treatment for Pediatric Atopic Dermatitis?
Many parents hesitate to use steroids on their children for extended periods. This hesitation is often due to fear of side effects like skin thinning (atrophy) or topical steroid withdrawal.
Non-steroidal treatment for pediatric atopic dermatitis provides a safety net for long-term management. These medications allow for continuous care without the specific risks associated with corticosteroids.
They are particularly useful for sensitive areas. The face, eyelids, and groin are areas where skin is thinner and more susceptible to steroid damage.
Additionally, non-steroidal options act as “steroid-sparing” agents. This means they can help maintain clear skin after a steroid has brought a flare-up under control.
Topical Calcineurin Inhibitors (TCIs)
Topical calcineurin inhibitors (TCIs) have been a cornerstone of non-steroidal eczema care for years. They work by blocking a protein called calcineurin, which activates the immune system’s T-cells.
By preventing T-cell activation, TCIs stop the release of chemicals that cause inflammation and itching. There are two main types available by prescription.
- Pimecrolimus (Elidel) is a cream often prescribed for mild to moderate cases.
- Tacrolimus (Protopic) is an ointment generally used for moderate to severe eczema.
A major benefit of TCIs is that they do not cause skin thinning or spider veins. This makes them excellent for use on the face and neck.
However, they can cause a burning or stinging sensation upon application. This side effect usually improves after a few days of use.
Phosphodiesterase-4 (PDE4) Inhibitors
Science continues to evolve, bringing us newer classes of medication like PDE4 inhibitors. Crisaborole (Eucrisa) is the primary topical medication in this category currently approved for children.
This non-steroidal treatment for pediatric atopic dermatitis works differently than TCIs. It penetrates the skin to block an enzyme called phosphodiesterase-4.
In people with eczema, PDE4 is overactive, leading to excessive inflammation. By blocking it, Crisaborole reduces redness, swelling, and itching.
It is approved for children as young as three months old with mild to moderate atopic dermatitis. It comes in an ointment form that also helps hydrate the skin barrier.
Like TCIs, stinging upon application can occur. However, studies show it is generally well-tolerated and effective for maintenance therapy.
Janus Kinase (JAK) Inhibitors
JAK inhibitors represent a cutting-edge advancement in dermatology. These medications target the Janus kinase pathway, a specific signaling route that drives itching and inflammation.
Ruxolitinib (Opzelura) is a topical JAK inhibitor cream. It is approved for short-term and non-continuous chronic use in adolescents and older children.
This treatment acts quickly to interrupt itch signals. Many patients report significant relief within days of starting the medication.
Because it is a potent medication, providers carefully monitor its use. It carries specific warnings, so a thorough discussion with your practitioner is essential.
Biologic Therapies for Severe Cases
For children with uncontrolled, moderate-to-severe eczema, topical creams may not be enough. This is where biologics like Dupilumab (Dupixent) come into play.
Dupilumab is an injectable medication approved for children as young as six months. It specifically blocks two proteins, interleukin-4 (IL-4) and interleukin-13 (IL-13).
These proteins are key drivers of type 2 inflammation, which causes eczema symptoms. By blocking them, Dupilumab heals the skin from the inside out.
According to a 2024 study, Dupilumab significantly improved the signs and symptoms of severe atopic dermatitis in children. The study highlighted that many participants achieved clear or almost clear skin.
Another biologic, Tralokinumab (Adbry), targets IL-13 specifically. As research progresses, more biologic options are likely to become available for pediatric patients.
The Role of Moisturizers and Barrier Repair
While prescription medications are vital, they work best alongside proper skincare. A non-steroidal treatment for pediatric atopic dermatitis includes barrier repair creams.
These are not just standard lotions. Prescription moisturizers mimic the natural lipids (fats) of the skin.
They help repair the skin barrier to keep moisture in and irritants out. Ingredients often include ceramides, hyaluronic acid, and shea butter.
Using these consistently can reduce the frequency of flare-ups. They serve as the foundation upon which prescription treatments work.
Lifestyle Changes to Support Treatment
Medication is one puzzle piece, but lifestyle triggers must also be managed. Identifying allergens is a critical step in non-steroidal management.
Common triggers include harsh soaps, fragrances, and rough fabrics like wool. Switching to cotton clothing and fragrance-free detergents can make a massive difference.
Dietary triggers are less common than environmental ones but should be considered. If you suspect a food allergy, consult an allergist rather than guessing.
Stress management is also important, even for children. Stress can trigger itch-scratch cycles that worsen the condition.
When to See a Dermatology Provider
If over-the-counter hydrocortisone is no longer working, it is time to seek professional help. Persistent itching that disrupts sleep is a clear sign that treatment needs adjustment.
A dermatology practitioner can evaluate if a non-steroidal treatment for pediatric atopic dermatitis is right for your child. They will assess the severity and location of the eczema.
They can also guide you on how to transition from steroids to non-steroidal options. This usually involves a tapering schedule to prevent rebound flare-ups.
Regular follow-ups ensure the chosen treatment remains effective. Pediatric skin conditions can change as the child grows, requiring adjustments in therapy.
Finding the Right Non-Steroidal Treatment for Pediatric Atopic Dermatitis in Phoenix, AZ
Navigating eczema treatments can be overwhelming for any parent. You want relief for your child without compromising their long-term health.
Fortunately, the landscape of eczema care has changed for the better. You no longer have to rely solely on steroids to manage this chronic condition.
At Happy Skin Pediatric Dermatology, we specialize in pediatric skin conditions. We understand the unique challenges of treating young skin and the anxiety that comes with eczema flare-ups.
Our providers are up-to-date on the latest non-steroidal therapies. We work with you to create a customized plan that fits your child’s needs and your family’s lifestyle.
Reach out to us today by calling (602) 837-3376 or using our online appointment request form.
